| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.2 |